| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 61.15B | 59.78B | 56.15B | 50.13B | 42.98B | 40.77B |
| Gross Profit | 21.52B | 17.61B | 16.17B | 13.84B | 10.83B | 11.33B |
| EBITDA | 12.39B | 14.11B | 12.52B | 10.51B | 7.34B | 10.57B |
| Net Income | 11.30B | 10.31B | 9.27B | 9.03B | 5.25B | 8.53B |
Balance Sheet | ||||||
| Total Assets | 275.46B | 272.33B | 246.55B | 230.68B | 199.02B | 200.05B |
| Cash, Cash Equivalents and Short-Term Investments | 2.63B | 42.59B | 39.19B | 33.79B | 25.79B | 97.91B |
| Total Debt | 17.47B | 17.65B | 15.29B | 14.49B | 14.88B | 16.17B |
| Total Liabilities | 195.54B | 192.55B | 178.15B | 166.99B | 148.50B | 140.34B |
| Stockholders Equity | 73.79B | 73.76B | 64.02B | 59.51B | 50.52B | 59.71B |
Cash Flow | ||||||
| Free Cash Flow | 15.90B | 14.54B | 16.18B | 12.63B | 11.26B | 11.15B |
| Operating Cash Flow | 15.90B | 14.54B | 16.18B | 12.63B | 11.26B | 11.15B |
| Investing Cash Flow | -14.00B | -12.98B | -13.92B | -7.65B | -5.65B | -6.66B |
| Financing Cash Flow | -1.68B | -1.85B | -2.18B | -4.49B | -5.14B | -4.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | $65.27B | 9.17 | 24.14% | 1.49% | 4.12% | 83.05% | |
82 Outperform | $57.14B | 5.47 | 42.71% | 1.91% | 4.40% | 209.62% | |
78 Outperform | $127.37B | 13.86 | 15.65% | 1.22% | 8.26% | 35.89% | |
77 Outperform | $25.40B | 12.62 | 19.48% | 1.88% | 6.61% | 9.14% | |
74 Outperform | $118.39B | 10.30 | 35.45% | 2.20% | 13.89% | 32.56% | |
68 Neutral | $23.26B | -25.32 | 9.84% | ― | 2.96% | 1.82% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |